FMO5 and endothelial dysfunction: In addition, bilirubin inhibits the protein kinase C and NAD(P)H oxidase pathway that generate oxidants, uncouples eNOS, leads to endothelial dysfunction [25], and suppresses the peroxidation of lipid and lipoproteins, a crucial step in the initiation and progression of atherosclerosis [26].